Understanding the interactions between these high-risk genes and any connections with HSPGs, identified as contributors to AD risk such as SDC3 and GPC4, will improve our knowledge of drivers in AD and other neurodegenerative diseases. This evidence concerns the gene GPC4 and Alzheimer disease.